Frontiers - Oncology

Follow along for the latest research, updates and news from all @FrontiersIn journals in the field of oncology 👀

🚀 Sarcoma Awareness Month is wrapping up! Don’t miss the latest research from our Hematologic Malignancies. Click here 👉 fro.ntiers.in/FHM #Oncology #CancerResearch #OpenAccess

📢 During World Hepatitis Day Explore the latest papers in our Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers in Frontiers in Oncology! Check it here 👉 fro.ntiers.in/FGIHPB #Oncology #CancerResearch #OpenAccess

🧬 New insights in cancer research! Check out the latest study on Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial: fro.ntiers.in/511816 #Oncology #CancerResearch #OpenAccess

Looking to make an impact in academic publishing? We're seeking new Associate Editors for our Editorial Board! 📝 Help us expand open-access and connect with passionate peers. Apply now: frontiersin.org/editors/join-a… #EditorOpportunity

New Research: Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach frontiersin.org/articles/10.33… #FrontiersIn #OncologyReviews

📄 Just published! Explore our latest paper, Artificial intelligence-based automated breast ultrasound radiomics for breast tumor diagnosis and treatment: a narrative review 👉fro.ntiers.in/1033892 #Oncology #CancerResearch #OpenAccess

New Research: Genetic counseling for hereditary cancer syndromes: a 5-year experience from a single center in Bulgaria frontiersin.org/articles/10.33… #FrontiersIn #OncologyReviews

🌟 Host Your Own Article Collection in Cardio-Oncology 🌟 Interested in curating a collection on your favorite topic? Host with us and showcase important research to a wider audience! Apply here 👉 frontiersin.org/research-topic…

New Research: Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report frontiersin.org/articles/10.33…

📣 Call for papers! Submit to our new Research Topic on AntibodyPlus Therapeutics in Oncology 👉 fro.ntiers.in/antibodyplus #callforpapers #openaccess

📣 Call for papers! Submit to our new Research Topic, AI-Powered Insights: Predicting Treatment Response and Prognosis in Breast Cancer 👉 fro.ntiers.in/69011 #callforpapers #openaccess

New Research: Mitophagy in the mechanisms of treatment resistance in solid tumors frontiersin.org/articles/10.33… #FrontiersIn #OncologyReviews

📣 Call for papers! Submit to our new Research Topic on Artificial Intelligence Advancing Lung Cancer Screening and Treatment 👉 frontiersin.org/research-topic…

🧬 New insights in cancer research! Check out the latest study on Analysis of Lymphocytic Leukemia trends: fro.ntiers.in/7NxC #Oncology #CancerResearch #OpenAccess

🧠 Have a groundbreaking idea for breast cancer research? We’re always seeking fresh Research Topics in our Breast Cancer section! Share your ideas or propose a theme to help shape the future of discovery. Get involved: fro.ntiers.in/breast-cancer-… #BreastCancerResearch #openaccess

📄 Just published! Explore our latest paper, Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA-mutated high-risk HER2-negative early breast cancer 👉fro.ntiers.in/10338

⏳ Don't miss out! Submit to our Research Topic Gynecological Cancer Prevention in Women with Inherited Genetic Risk 👉 fro.ntiers.in/685382 Hosted by the Specialty Chief Editor of our Gynecological Oncology section, Dr. Robert Fruscio

⏳ Don't miss out! Submit to our Research Topic on Cancer Burden and Cancer Screening Strategies in Asia 👉 fro.ntiers.in/fChS #callforpapers #openaccess

Looking to make an impact in academic publishing? We're seeking new reviewers for our Editorial Board! 📝 Help us expand open-access and connect with passionate peers. Apply now: frontiersin.org/editors/join-a… #ReviewerOpportunity

New Research: Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities frontiersin.org/articles/10.33… #FrontiersIn #OncologyReviews